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Abstract
Replication of plus-strand RNA viruses depends on host factors that are recruited into viral replicase complexes. Previous
studies showed that eukaryotic translation elongation factor (eEF1A) is one of the resident host proteins in the highly
purified tombusvirus replicase complex. Using a random library of eEF1A mutants, we identified one mutant that decreased
and three mutants that increased Tomato bushy stunt virus (TBSV) replication in a yeast model host. Additional in vitro assays
with whole cell extracts prepared from yeast strains expressing the eEF1A mutants demonstrated several functions for
eEF1A in TBSV replication: facilitating the recruitment of the viral RNA template into the replicase complex; the assembly of
the viral replicase complex; and enhancement of the minus-strand synthesis by promoting the initiation step. These roles for
eEF1A are separate from its canonical role in host and viral protein translation, emphasizing critical functions for this
abundant cellular protein during TBSV replication.
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Introduction
Genome-wide screens for host factors affecting RNA virus
infections have led to the identification of several hundreds host
proteins in recent years [1,2,3,4,5,6,7]. These works demonstrated
complex interactions between the host and plus-stranded (+)RNA
viruses, the largest group among viruses. (+)RNA viruses contain
relatively small genomes and greatly depend on the resources of
the infected hosts in many steps during the infection process.
These viruses recruit numerous host proteins to facilitate their
replication and spread [8,9,10]. Many host RNA-binding proteins
have been implicated in replication of (+)RNA viruses, including
ribosomal proteins, translation factors and RNA-modifying
enzymes [8,9,10,11,12,13,14]. In spite of the extensive effort, the
actual function of host factors in (+)RNA virus replication is known
only for a small number of host factors [8,10,15,16,17].
Tomato bushy stunt virus (TBSV) and other tombusviruses are
model plant RNA viruses with 4.8 kb genomic (g)RNA coding for
two replication proteins, termed p33 and p92
pol, and three
proteins involved in cell-to-cell movement, encapsidation, and
suppression of gene silencing [18,19]. Yeast (Saccharomyces cerevisiae)
expressing p33 and p92
pol replication proteins can efficiently
replicate a short TBSV-derived replicon (rep)RNA [20,21]. The
tombusviral repRNA plays several functions, including serving as a
template for replication and as a platform for the assembly of the
viral replicase complex [19,22,23]. The viral RNA also partici-
pates in RNA recombination [6,18,24], which likely plays a major
role in virus evolution.
One of the major advantages of studying TBSV replication is
the availability of genomic and proteomic datasets on virus-host
interactions [4,5,6,7,10,15,25,26,27]. For example, systematic
genome-wide screens of yeast genes have revealed that TBSV
repRNA replication is affected by over 100 different host genes
[5,7]. Additional genome-wide screens with TBSV also identified
,30 host genes affecting TBSV RNA recombination [4,6,28].
The identified host genes code for proteins involved in various
cellular processes, such as translation, RNA metabolism, protein
modifications and intracellular transport or membrane modifica-
tions [3,5,7].
Additional global approaches based on the yeast proteome
microarray (protein array) have led to the identification of over
100 host proteins that interact with viral RNA or the viral
replication proteins [25,26]. Also, proteomics approaches with the
highly purified tombusvirus replicase has determined at least seven
proteins in the complex, including the viral p33 and p92
pol, the
heat shock protein 70 chaperones (Hsp70, Ssa1/2p in yeast),
glyceraldehyde-3-phosphate dehydrogenase (GAPDH, encoded by
TDH2 and TDH3 in yeast), pyruvate decarboxylase (Pdc1p),
Cdc34p ubiquitin conjugating enzyme [14,26,27] and eukaryotic
translation elongation factor 1A (eEF1A) [25]. The functions of
GAPDH and Hsp70 have been studied in some detail
[14,29,30,31], but the roles of the other host proteins, such as
eEF1A, in the replicase complex are currently undefined.
eEF1A is a highly abundant cellular protein with a role in
delivering aminoacyl-tRNA to the elongating ribosome in a GTP-
dependent manner. Many additional functions have been ascribed
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ubiquitin-dependent protein degradation, and organization of the
actin cytoskeleton [32,33]. Although eEF1A has been shown to be
part of replicase complexes of several RNA viruses [16,34,35,36],
studies on determining its functions in virus replication are
hindered by several major difficulties. These include (i) genetic
redundancy: yeast has two eEF1A genes (TEF1 and TEF2),
whereas animals and plants have 2–7 genes and several isoforms of
eEF1A. (ii) eEF1A provides essential functions for cell viability and
mutations could have pleiotropic effects on protein translation,
actin bundling and apoptosis. (iii) eEF1A is a very abundant
protein that constitutes 1–5% of total cellular proteins, making it
difficult to completely remove eEF1A from biochemical assays
using cell extracts. (iv) eEF1A is also required for the translation of
viral proteins in infected cells, making it difficult to separate its
effect on translation versus replication, processes that are
interdependent.
The first evidence that translation elongation factors, such as
EF-Tu and EF-Ts, play a role in (+)RNA virus replication was
obtained with bacteriophage Qbeta [34]. The eukaryotic homolog
of EF-Tu, eEF1A was found to bind to many viral RNAs,
including the 39-UTR of Turnip yellow mosaic virus (TYMV) [37],
West Nile virus (WNV), Dengue virus, Tobacco mosaic virus (TMV)
and Turnip mosaic virus (+)RNA [35,38,39,40]. In addition, eEF1A
has also been shown to interact with various viral replication
proteins or the replicases, such as the NS5A replication protein of
Bovine viral diarrhea virus (BVDV) [41], NS4A of hepatitis C
virus (HCV) [42], the TMV replicase [43], and the Gag
polyprotein of HIV-1 [44]. It is also part of the replicase complex
of vesicular stomatitis virus, a negative-stranded RNA virus [45].
The actual biochemical functions provided by eEF1A for
(+)RNA virus replication are currently poorly understood. In case
of WNV, eEF1A is co-localized with the WNV replicase in the
infected cells and mutations in the WNV (+)RNA within the
mapped eEF1A binding site have led to decreased minus-strand
synthesis [46]. On the contrary, eEF1A was shown to enhance
translation but repressed minus-strand synthesis of TYMV in vitro
[37,47,48]. Overall, eEF1A likely plays a role in the replication of
many RNA viruses. The interactions of eEF1A with viral RNAs
and viral replication proteins and its high abundance in cells might
facilitate recruitment of eEF1A into virus replication.
eEF1A has been shown to interact with the components of the
tombusvirus replicase, including the 39-UTR of the repRNA, as
well as the p33 and p92
pol replication proteins [25]. eEF1A is also
known to interact with the yeast Tdh2p (GAPDH) [49], which is
also a component of the tombusvirus replicase. Overall, the
multiple interactions of eEF1A with various components of the
tombusvirus replicase could be important for eEF1A to regulate
yet unknown functions of the viral replicase complex.
In this paper, we characterized the functions of eEF1A in TBSV
replication based on identification of functional eEF1A mutants in
yeast as well as using in vitro approaches. The obtained data
support the model that eEF1A plays several roles during TBSV
replication, including facilitating the assembly of the viral replicase
complex. Moreover, using in vitro replication assays, we demon-
strate that eEF1A enhances minus-strand synthesis via stimulating
the initiation step of the viral RNA-dependent RNA polymerase.
Since eEF1A is also associated with several other viral replication
proteins or binds to viral RNAs, it is possible that the uncovered
functions of eEF1A might be utilized by other RNA viruses during
their replication as well.
Results
Identification of eEF1A mutants affecting TBSV RNA
accumulation
To determine the functions of eEF1A during tombusvirus
replication, we generated ,6,000 yeast strains expressing eEF1A
with random mutations (see Fig. S1A) and tested the level of
TBSV repRNA accumulation in a high-throughput assay [50]. In
this assay, we used yeast strains, in which the two wt eEF1A genes
(TEF1/TEF2) were deleted from the chromosome, while the wt or
mutated eEF1A was expressed from plasmids. Importantly, a
given eEF1A mutant is the only source of eEF1A in the yeast cells
used. Using the high-throughput assay, we identified one yeast
strain (N21) expressing an eEF1A mutant that supported reduced
TBSV repRNA replication, while the other three strains with
eEF1A mutants (named C42, C53 and C62) showed increased
level of repRNA accumulation (Fig. 1A and S1B–G). Interestingly,
the eEF1A mutants supporting increased steady-state level of
repRNA accumulation did not increase the relative level of p33
and p92
pol replication proteins (Fig. 1A, bottom panel; S1D–E).
Thus, these eEF1A mutants likely affect TBSV replication directly.
Accordingly, affinity purification of the solubilized tombusvirus
replicase complex from yeast cells, followed by in vitro replicase
activity assay revealed that the replicase from C42, C53 and C62
mutant eEF1A-expressing yeast strains had ,2-fold increased
activities when compared with wt eEF1A-expressing yeast strain
(Fig. 1B, lanes 1–6 versus 7–8). The amounts of replication protein
p33 and the co-purified eEF1A were comparable in the purified
replicase samples (Fig. 1B, bottom panel), indicating that the
differences in replicase activities in the mutants are likely due to
enhanced replicase functions, and not due to altered proteins levels
in the replicase complexes. Testing the ability of C42, C53 and
C62 mutant eEF1As to bind to the viral RNA or to the p33 and
p92
pol replication proteins in vitro (Fig. S2B–C) did not reveal
significant differences between the mutants and the WT. This
further supports that these eEF1A mutations likely increase the
function of the viral replicase without altering the protein and
RNA components in the replicase.
Placing the identified mutations in the three novel gain-of-
function mutants of eEF1A (V301D, L374V/N377K, and F413L;
Fig. 1C, indicated with yellow balls), which exhibited increased
tombusvirus replication, over the known structure of eEF1A [51]
revealed a cluster on one face of eEF1A (namely, the actin
bundling domain III), away from the domains known to bind to
tRNA and translation factor eEF1Ba. On the other hand, the new
reduced function mutant (A76V, Fig. 1C, indicated with green
balls) and the previously identified T22S [25], which exhibited
Author Summary
Plus-stranded RNA viruses are important pathogens of
plants, animals and humans. They replicate in the infected
cells by assembling viral replicase complexes consisting of
viral- and host-coded proteins. In this paper, we show that
the eukaryotic translation elongation factor (eEF1A), which
is one of the resident host proteins in the highly purified
tombusvirus replicase complex, is important for Tomato
bushy stunt virus (TBSV) replication in a yeast model host.
Based on a random library of eEF1A mutants, we identified
eEF1A mutants that either decreased or increased TBSV
replication. In vitro studies revealed that eEF1A facilitated
the recruitment of the viral RNA template for replication
and the assembly of the viral replicase complex, as well as
eEF1A enhanced viral RNA synthesis in vitro. Altogether,
this study demonstrates that eEF1A has several functions
during TBSV replication.
eEF1A Role in the Assembly of Virus Replicase
PLoS Pathogens | www.plospathogens.org 2 November 2010 | Volume 6 | Issue 11 | e1001175eEF1A Role in the Assembly of Virus Replicase
PLoS Pathogens | www.plospathogens.org 3 November 2010 | Volume 6 | Issue 11 | e1001175decreased tombusvirus replication, showed a distinct and separate
localization.
eEF1A mutants enhance TBSV RNA replication in a cell-
free extract
Since eEF1A is part of the tombusvirus replicase complex [25],
it is possible that C42, C53 and C62 eEF1A mutants might affect
the assembly/activity of the tombusvirus replicase. To test this
idea, we prepared cell-free extracts (CFE) from yeast strains
expressing selected eEF1A mutants in the absence of the wt copy
of eEF1A. These yeast extracts contained comparable amount of
total proteins as well as the amounts of eEF1A, ALP, PGK and
Hsp70 (Ssa) yeast proteins were comparable (Fig. 2A). The
advantage of the CFE extracts is that they can then be
programmed with the TBSV (+)repRNA in the presence of
purified recombinant p33 and p92
pol obtained from E. coli that
leads to the in vitro assembly of the viral replicase, followed by a
single cycle of complete TBSV replication, resulting in both (2)-
stranded repRNA and (+)-stranded progeny [31,52]. Therefore,
this assay can uncouple the translation of the viral proteins from
viral replication, which are interdependent during (+)RNA virus
infections.
Using CFEs from yeast expressing one of the three mutant
eEF1As resulted in ,3-fold increased TBSV repRNA accumula-
tion when compared with the extract obtained from yeast
expressing the wt copy of eEF1A (Fig. 2A, lanes 2–4 versus 5).
These data suggest that the viral replicase complex containing the
mutant eEF1A can support in vitro TBSV repRNA replication
more efficiently than the replicase with the wt eEF1A. In contrast,
CFE from N21 yeast supported TBSV repRNA replication to
similar extent as the CFE containing wt eEF1A (Fig. 2A, lanes 1
versus 5), indicating that N21 eEF1A mutant can perform the
same functions as the wt eEF1A in vitro, when the same amount of
p33 and p92
pol was provided.
To test if the increased TBSV repRNA replication in vitro was
due to enhanced (+)o r( 2)-strand synthesis, we analyzed the
replication products under non-denaturing versus denaturing
conditions (Fig. 2B). These experiments showed that the amount
of dsRNA [representing the
32P-labeled (2)RNA product
hybridized with the (+)RNA] increased ,3-fold in case of C42,
C53 and C62 mutants (lanes 3–8, Fig. 2B) in comparison with the
wt (lanes 9–10). The dsRNA nature of these products was
confirmed by the ssRNA-specific S1 nuclease digestion assay
(Fig. 2C). On the other hand, the ratio of dsRNA and ssRNA did
not change in the various CFEs containing the eEF1A mutants or
the wt (Fig. 2B). These results are consistent with the model that
the replicase complex carrying the eEF1A mutants increased
mostly the level of (2)RNA production, which then led to
proportionately higher level of (+)RNA progeny.
Cell-fractionation assay, followed by the cell-free TBSV
replication assay demonstrated that the soluble fraction from the
C42, C53 and C62 mutant yeasts stimulated the in vitro replication
of TBSV repRNA by ,3-fold, while the membrane fraction when
derived from C42, C53 and C62 mutant yeasts had a lesser effect
(Fig. 2D, lanes 12–14 versus 7–9). These data are in agreement
with the expected mostly cytosolic distribution of eEF1A, albeit
eEF1A is also present in the membrane fraction in a smaller
amount (Fig. 2D, bottom panel).
eEF1A stimulates initiation of (2)RNA synthesis by a viral
RdRp in vitro
To test directly if eEF1A could stimulate RNA synthesis by the
viral RdRp, we chose the E. coli-expressed recombinant p88
pol
RdRp protein of Turnip crinkle virus (TCV), which is unlike the E.
coli-expressed TBSV or CNV p92
pol RdRp, does not need the
yeast cell-free extract to be functional in vitro [53,54]. The template
specificity of the recombinant TCV RdRp with TBSV RNAs is
similar to the closely-related tombusvirus replicase obtained from
yeast or infected plants [21,54,55,56]. However, the recombinant
TCV RdRp preparation lacks co-purified eEF1A, unlike the yeast
or plant-derived tombusvirus replicase preparations, facilitating
studies on the role of eEF1A on the template activity of a viral
RdRp. When we added the highly purified wt eEF1A to the RdRp
assay containing TCV RdRp protein and a TBSV derived
(+)RNA template, which is used by the TCV RdRp in vitro to
produce the complementary (2)RNA product (Fig. 3A, lanes 3–4)
[55], we observed a ,6-fold increase in (2)RNA synthesis by the
TCV RdRp (lanes 11–12), while, as expected, we did not detect
new (+)RNA progeny (not shown). This suggests that eEF1A can
greatly stimulate TCV RdRp activity in vitro, confirming a direct
role for eEF1A in (2)RNA synthesis by a viral RdRp.
Since it is known that eEF1A can bind to the 39-UTR of TBSV
(+)RNAaswellas to the tombusvirus replication proteins [25] and to
the TCV RdRp (Fig.S2A),wewanted totest ifthe abovestimulating
activity of eEF1A in the in vitro RdRp assay was due to binding of
eEF1A to the (+)RNA template and/or to the TCV RdRp protein.
Pre-incubation of the purified wt eEF1A with the TCV RdRp prior
to the RdRp assay led to a ,5-fold increase in in vitro (2)RNA
synthesis (Fig. 3A, lanes 9–10), while pre-incubation of the purified
eEF1A withthe TBSV(+)RNAtemplatepriortothe RdRpassayled
onlytoa,2-foldincreasein(2)RNAproducts(lanes7–8).Also,pre-
incubation of the TCV RdRp with the (+)RNA template prior to the
RdRp assay containing purified eEF1A led only to a ,2-fold
increase in (2)RNA synthesis (lanes 5–6), suggesting that eEF1A can
stimulate (2)RNA synthesis less efficiently after the formation of the
(+)RNA-RdRp complex. Overall, data shown in Fig. 3 imply that
eEF1A stimulates (2)RNA synthesis most efficiently when it forms a
complex with the viral RdRp prior to binding of the template RNA
to the eEF1A-RdRp complex.
To test if eEF1A stimulates the rate of initiation of (2)RNA
synthesis, we analyzed the amount of abortive RNA products,
which are generated during de novo initiation of RNA synthesis by
the TCV RdRp [57]. We found that the amount of the 5–11 nt
long abortive RNA products increased by 3.5-fold in the presence
of purified eEF1A in the TCV RdRp assay (Fig. 3B, lanes 3–4
versus 1–2). We also tested the RdRp activity in the presence of
Figure 1. The effect of eEF1A mutations on TBSV repRNA accumulation in yeast. (A) The yeast strains expressed only one form of eEF1A, as
indicated. Top panel: Replication of the TBSV repRNA was measured by Northern blotting 24 h after initiation of TBSV replication. The accumulation
level of repRNA was normalized based on the rRNA (middle panel, the 18S ribosomal RNA levels were estimated by Northern blotting). Bottom two
panels: Accumulation of p33/p92
pol and eEF1A was estimated by Western blotting using anti-His and anti-eEF1A antibody, respectively. Note that *
marks an SDS-resistant p33 homodimer band. (B) An in vitro replicase assay to test the relative activity of the tombusvirus replicase obtained from
yeast expressing various mutants of eEF1A. Top panel: We tested the in vitro replicase activity using comparable amounts of affinity-purified replicase
with added DI-72 RI(2) RNA template. Bottom panels: Western blot analysis showing p33 viral replication protein and the co-purified eEF1A in the
above purified replicase preparations. (C) Critical eEF1A residues for tombusvirus replication. Three novel mutants of eEF1A were identified, which
exhibited increased tombusvirus replication (V301D, L374V/N377K, and F413L; yellow balls) while the new A76V and the previously identified T22S
exhibited decreased tombusvirus replication (green balls). The structure of eEF1A was generated using Jmol with PDB coordinates 1IJE.
doi:10.1371/journal.ppat.1001175.g001
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closed structure in the promoter region that leads to increased
template activity [58]. The mutated template also showed 2-fold
increased abortive RNA products in the RdRp assay with eEF1A
(Fig. 3B, lanes 5 versus 6). These data strongly support the model
that eEF1A stimulates the de novo initiation step in the RdRp assay.
Figure 2. Cell-free TBSV replicase assay supports a role for eEF1A in minus-strand synthesis. (A) Purified recombinant p33 and p92
pol
replication proteins of TBSV in combination with DI-72 (+)repRNA were added to the whole cell extract prepared from eEF1A mutant or WT yeast
strains as shown (lanes 1–5). Top panel: The denaturing PAGE analysis of the
32P-labeled repRNA products obtained is shown. The full-length repRNA
is pointed at by an arrow. Panels below show Western blot analysis of the whole cell extracts for the indicated yeast proteins based on specific
antibodies. Bottom panel shows the coomassie-blue stained SDS-PAGE gel to visualize total protein levels in the whole cell extracts. (B) Detection of
single- and double-stranded RNA products produced in the cell-free TBSV replicase assay. Odd numbered lanes represent replicase products, which
were not heat treated (thus both ssRNA and dsRNA products are present), while the even numbered lanes show the heat-treated replicase products
(mostly ssRNA is present). The amount of dsRNA and the ratio of ssRNA/dsRNA in the samples are shown. Note that, in the nondenatured samples,
the dsRNA product represents the annealed (2)RNA and the (+)RNA, while the ssRNA products represents the newly made (+)RNA products. (C)
Denaturing PAGE analysis of the TBSV replicase products obtained in the cell-free replicase assay after S1 nuclease treatment, which cleaves the
ssRNA, but not the dsRNA product. (D) The denaturing PAGE analysis of the
32P-labeled repRNA products obtained in the in vitro reconstitution assay
is shown. The membrane fraction of the whole cell extracts prepared from eEF1A mutant strains were mixed with the supernatant fraction of CFE
prepared from WT eEF1A (lanes 6–10) or the supernatant fraction of CFE from the mutant strains were added to the membrane fraction from the wt
strain (lanes 11–15). The reconstituted extracts were programmed with purified recombinant TBSV p33/p92
pol and (+)repRNA. Bottom panel: Western
blot analysis shows the amount of endogenous eEF1A in various fractions (see above) prepared from yeast expressing various mutants of eEF1A.
doi:10.1371/journal.ppat.1001175.g002
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absence of de novo initiation, we analyzed the amount of 39-
terminal extension (39-TEX) RNA products, which are generated
from an internal primer by the TCV RdRp (Fig. 3D) [55].
Addition of purified eEF1A did not increase the amount of 39TEX
products (lanes 2, 4, 6, Fig. 3D), suggesting that the elongation step
Figure 3. eEF1A promotes the initiation by the TCV RdRp during minus-strand synthesis. (A) Purified eEF1A was added to the TCV RdRp
assay as shown. The TBSV (+)RNA template was the short 39 end region (SL1/SL2/SL3), which contain the promoter region (SL1) for initiation and the
replication silencer element (within SL3) that down-regulates initiation. The second template was SL1m with a point mutation within the promoter
sequence, which is being used more efficiently by the TCV RdRp in vitro. Note that eEF1A has been shown to bind to the replication silencer element.
The RdRp assay had two steps: first, the shown components were incubated at room temperature to facilitate their interaction, followed 5 min latter
the addition of the shown component and the ribonucleotides to start RNA synthesis. The RdRp activity in samples containing the template RNA and
the RdRp were chosen as 100% (lanes 3–4). (B) Detection of abortive RdRp products in the in vitro assay. 15% PAGE/UREA gel was used to resolve the
4–10 nt long products produced during initiation followed by rapid termination. Note that abortive RNA products are characteristic products for RNA
polymerases that initiate de novo (in the absence of a traditional primer). (C) Lack of stimulation of 39-terminal extension by eEF1A in vitro. The
template RNAs (shown schematically) contain a common artificial hairpin structure at the 39 end that facilitates 39-TEX by the TCV RdRp. The black bar
represents 3 different sequences in the three constructs, derived from RIV(+)(includes SL1/SL2/SL3 sequences), RIII(2) and RIII(+) of DI-72 RNA,
respectively. The gel image shows the results of 39-TEX in the presence of 0 or 1 mg eEF1A as shown in a TCV RdRp assay.
doi:10.1371/journal.ppat.1001175.g003
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Altogether, the obtained in vitro TCV RdRp data suggest that
eEF1A can mostly stimulate the initiation step during de novo viral
(2)RNA synthesis.
Inhibition of replicase activity and template recruitment
by inhibitors of eEF1A in vitro
To further test the function of eEF1A in TBSV replication, we
used chemical inhibitors of eEF1A, including Didemnin B (DB)
and Gamendazole (GM). DB inhibits the activity of GTP-bound
eEF1A during translation by binding to a pocket in eEF1A
involved in the interaction with the aminoacylated tRNA and the
nucleotide exchange factor eEF1Balpha [59,60]. GM has been
shown to inhibit the actin bundling function, while it does not
inhibit protein translation or GTP binding functions of eEF1A
[61]. We found that both DB and GM efficiently inhibited TBSV
repRNA replication in the in vitro assay with CFE, which contains
the endogenous eEF1A (Fig. 4A). Time-course experiments
revealed that the inhibition by DB was the most effective when
the inhibitor was added at the beginning or during the first 10–
15 min of the assay (Fig. 4B, lanes 2–5), while GM inhibited the
cell-free replication of TBSV repRNA when added not only at the
beginning, but up to 40 min after the start of the assay (lanes 12–
17). It is known that the recruitment of the viral RNA and
replication proteins as well as the assembly of the viral replicase
complex take place during the first 40–60 min in the cell-free assay
[31]. Since DB could inhibit translation, we also tested the effect of
another translation inhibitor, namely cycloheximide, which did
not affect TBSV repRNA replication in our assay (Fig. S3). These
data suggest that the inhibition by DB and GM is unlikely through
decreased translation in the replication assay. Therefore, the above
data are consistent with the model that DB and GM interfere with
the assembly of the viral replicase complex in the CFE. Also, GM
seems to be a more potent inhibitor of TBSV replication than DB.
To further test if DB and GM can interfere with the assembly of
the tombusvirus replicase complex, we performed a two-step in
vitro assembly/replication assay, also based on CFE containing
endogenous eEF1A [31]. In this assay, first, we only provide ATP
and GTP in addition to the replication proteins, the (+)repRNA
and CFE, which can support the assembly of the replicase, but
cannot perform RNA synthesis due to the lack of CTP and UTP
[31]. After 1 hr incubation, once the replicase assembly had taken
place, we collected the membrane fraction of the CFE by
centrifugation and removed the supernatant containing the
unbound p33, p92, repRNA as well as the cytosolic fraction of
the CFE. Then we added all four rNTPs (including
32P-labeled
UTP) to the membrane fraction of the CFE to allow for RNA
synthesis by the pre-assembled replicase complex (second step,
Fig. 4C) [31]. Interestingly, adding either DB or GM during the
first step resulted in robust inhibition of TBSV repRNA synthesis
during the second step of the assay (Fig. 4C, lanes 2–3 versus 1),
whereas providing the same amount of DB and GM at the
beginning of the second step did not result in inhibition of repRNA
replication (lanes 4–6). These data support a model that DB and
GM could inhibit the assembly of the tombusvirus replicase
complex, but not the RNA synthesis by the already assembled
replicase. Similarly, DB and GM failed to inhibit TBSV RNA
synthesis in an in vitro assay with a highly purified RdRp from yeast
(Fig. S4A).
Since the assembly of the tombusvirus replicase also depends on
events prior to the replicase assembly step, such as template RNA
binding by the viral replication proteins/host proteins (such as
eEF1A), and template recruitment to intracellular membranes
[21,52], we also tested the effect of DB and GM on these processes
as well based on purified recombinant eEF1A. We found that GM
strongly interfered with the binding of eEF1A to the viral RNA in
an EMSA assay (Fig. 4D, lanes 3–6 versus 2), whereas DB did not
affect the binding under the assay conditions (lanes 9–12). Since
DB binds only weakly to eEF1A in solution, but it binds much
more effectively to eEF1A in the presence of GTP and the
ribosome [62], we also performed in vitro co-purification
experiments. First,
35S-labeled eEF1A was produced in an in
vitro translation system (containing ribosome and GTP) and,
second, biotin-labeled viral (+)repRNA was added. After short
incubation in the absence or presence of various amount of DB,
we performed affinity-purification of the viral RNA. Phosphoima-
ging revealed that eEF1A was co-purified with the viral RNA and
the amount of protein co-purified with the viral (+)repRNA was
inhibited by increasing amount of DB in the assay (Fig. 4E,
compare lane 1 with 2–5). This demonstrated that DB inhibits the
binding of eEF1A to the viral repRNA. Moreover, both DB and
GM interfered with the recruitment of the viral template RNA to
the membrane of the CFE containing endogenous eEF1A (Fig. 4F,
lanes 5–8 versus 3–4). On the other hand, DB and GM do not
seem to affect the interaction between eEF1A and p33 or p92
replication proteins in vitro (Fig. S4B). Altogether, these data
suggest that inhibition of eEF1A function by DB and GM could
block several steps during the assembly of the tombusvirus
replicase complex, including template binding by eEF1A and
viral RNA recruitment into replication.
Discussion
(+)RNA virus replicases contain viral- and host-coded compo-
nents, which likely provide many yet undefined functions to
facilitate robust virus replication in infected cells. Translation
factors, such as eEF1A, are among the most common host factors
recruited for (+)RNA virus replication. eEF1A is an integral
component of several viral replicases, including the highly purified
tombusvirus replicase complex. Since eEF1A is an essential G
protein involved in translation elongation, it is difficult to obtain
evidence for its direct involvement in virus replication in living
cells. Indeed, down-regulation of eEF1A in cells has led not only to
decreased TBSV repRNA accumulation, but also reduced p33
levels [25]. However, using a small set of functional eEF1A
mutants defective in various functions revealed that eEF1A is
involved in stabilization of p33 replication protein in yeast [25].
Based on the previous successful strategy of analyzing eEF1A
mutants, here we generated ,6,000 random mutants covering the
entire eEF1A sequence and found four mutants, which greatly
affected TBSV repRNA accumulation in yeast (Fig. 1A). Among
these mutants, C42, C53 and C62 increased TBSV repRNA
replication. Importantly, this effect by the eEF1A mutants was not
due to changing the translation efficiency of p33/p92
pol, but likely
via directly altering viral replication and affecting the activity of
the viral replicase. On the other hand, N21 mutant of eEF1A
resulted in decreased TBSV RNA accumulation and also led to
reduction in the level of p33 replication protein. This is
reminiscent of the previously characterized GDP-binding mutant
T22S [25], which supported greatly reduced level of viral RNA
replication and p33 accumulation due to shortened half-life of p33.
Overall, N21 mutant further supports that one of the functions of
eEF1A in TBSV replication is to stabilize the p33 replication
protein in yeast.
In addition to this genetic evidence on the relevance of eEF1A
in TBSV replication in yeast, we also obtained additional
supporting data by showing that chemical inhibitors of eEF1A,
such as DB and GM, strongly inhibited replication of TBSV
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the same amount of purified recombinant p33/p92
pol in this in vitro
assay (i.e., translation in the CFE is not needed for production of
p33/p92
pol), the role of eEF1A in TBSV replication must be
separate from its role in protein translation. Altogether, these data
strongly established that eEF1A is directly involved in TBSV
replication, independent of the role of eEF1A in protein
translation.
Figure 4. Inhibition of TBSV repRNA replication by Didemnin B and Gamendazole in a cell-free TBSV replicase assay. (A) The cell-free
TBSV replicase assay was performed as described in Fig. 2. DB and GM were added in the following amounts: 0, 50, 100, 150, 200, 250 mM for DB and
0, 5, 25, 50, 100, and 200 mM for GM, respectively. The replicase activity in the samples containing the DMSO solvent instead of DB or GM was chosen
as 100%. (B) Time course analysis was performed in a cell-free TBSV replicase assay as described in Fig. 2. DB (150 mM) and GM (100 mM) were added
at various time points and the replicase assay was stopped after 3 hours for each treatment, followed by RNA analysis in a denaturing PAGE gel. The
replicase activity in the samples containing DMSO added at the 0 time point was chosen as 100%. (C) A step-wise approach was used to separate the
possible effect of DB and GM during either the assembly of the TBSV replicase or RNA synthesis steps. In step 1, the purified recombinant TBSV p33,
p92
pol and (+)repRNA were added to the whole cell extract in the presence of ATP and GTP, which only supports the assembly of the TBSV replicase,
but prevents RNA synthesis. This was followed by removal of the extra amount of p33, p92
pol and repRNA, which were not bound to the membranes
of cell-free extract, and then by the standard replicase assay in a buffer containing
32P-UTP and ATP, CTP and GTP (step ‘‘RNA synthesis’’). The
denaturing PAGE analysis of the
32P-labeled repRNA products obtained is shown. Note that DB (150 mM) and GM (100 mM) were added to the assay
either at the beginning (prior to replicase assembly) or after the replicase assembly. See further details in panel B. (D) The effect of DB and GM on
binding between the purified eEF1A and
32P-labeled template RNA (SL1/SL2/SL3) based on EMSA. The bound and unbound RNAs are pointed at by
arrowheads. GM and DB were applied in the following amounts: 0, 5, 50, 250, and 1000 mM. Note that the amount of unbound RNA in the absence of
eEF1A (lane 1) was chosen as 100%. (E) The inhibitory effect of DB on co-purification of eEF1A with the viral repRNA. WT
35S-labeled eEF1A was
produced in a translation assay using rabbit reticulocyte lysate, followed by incubation with biotin-labeled DI-72(+) repRNA in the presence of 0, 50,
150, 500 and 1000 mM DB. Then the repRNA was captured with streptavidin-coated magnetic beads, followed by elution of the co-purified proteins
from the beads. SDS-PAGE analysis shows the amount of co-purified
35S-labeled eEF1A. (F) The inhibitory effect of DB and GM on the template
recruitment step in vitro. Purified recombinant p33/p92 and
32P-labeled DI-72 (+)repRNA (indicated as W, lanes 1 and 3–8) or C99-G mutant (+)repRNA
(indicated as M, lane 2) were added to a whole cell extract (CFE) in the presence of DMSO (control), 100 mM GM or 150 mM DB, followed by
centrifugation/washing to remove the
32P-labeled repRNA that is not bound to the membrane. Then the membrane-bound RNA was analyzed in a
denaturing PAGE gel. Note that the recruitment deficient C99-G mutant repRNA bound to the membrane nonspecifically (,20% level).
doi:10.1371/journal.ppat.1001175.g004
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during TBSV replication
The identified eEF1A mutants were also useful to dissect the
functions of eEF1A in TBSV replication. Based on a cell-free
TBSV replication assay in CFE prepared from yeast expressing
the C42, C53 or C62 mutants, we found that the minus-strand
synthesis was enhanced by ,3-fold, while the rate of plus-strand
synthesis was proportionate with (2)RNA synthesis, resulting in
,10-fold more (+) than (2)RNA products for wt and each mutant.
We confirmed a direct role for eEF1A in RNA synthesis in vitro
by using a highly purified eEF1A and the recombinant TCV
RdRp, which is closely homologous with the TBSV p92
pol.
Interestingly, it seems that eEF1A stimulates the RdRp activity
directly, since pre-incubation of eEF1A and the RdRp prior to the
RdRp assay led to the highest level of stimulation of (2)RNA
synthesis (Fig. 3A). On the other hand, pre-incubation of eEF1A
with the TBSV-derived template RNA led only to ,2-fold
increase in RNA synthesis in vitro (Fig. 3A). Analyzing the amount
of short abortive RdRp products, which are produced through
initiation followed quickly by abortive termination [57], in the in
vitro assays revealed that eEF1A strongly enhanced the initiation of
minus-strand synthesis (Fig. 3B). Although the actual mechanism
of stimulation of RdRp activity by eEF1A is currently unknown,
we propose that eEF1A might facilitate the proper and efficient
binding of the RdRp to the 39 terminal sequence of the viral RNA
prior to initiation of (2)-strand synthesis (Fig. 5). Accordingly,
eEF1A was shown to bind to the so-called replication silencer
sequence (RSE) in the 39-UTR, which is required for the assembly
of the viral replicase complex [22,58]. The binding of eEF1A-
RdRp complex to the RSE might assist in placing the RdRp over
the 39-terminal promoter sequence, thus facilitating the initiation
of (2)RNA synthesis starting from the 39-terminal cytosine.
Similar function of eEF1A in stimulation of (2)RNA synthesis
has been proposed for WNV, based on mutations in the viral RNA
within the eEF1A binding sequence that reduced the binding
affinity of RNA to eEF1A and inhibited (2)RNA synthesis in
infected cells [46].
eEF1A stimulates the assembly of the viral replicase
complex during TBSV replication
Recent intensive work revealed that the assembly of the viral
replicase complex is a regulated process involving viral- and host
factors, cellular membranes and the viral (+)RNA [8,10,19,
63,64,65]. The assembly of the viral replicase also depends on
steps occurring prior to the actual assembly process, such as
selection of the viral template RNA and the recruitment of
(+)RNA/protein factors to the sites of assembly. Although our
current understanding is rather poor about the factors involved
Figure 5. A model describing the functions of eEF1A during tombusvirus replication. eEF1A not only affects the stability of p33 in cells,
but it binds to both the p92
pol replication protein and the viral RNA, facilitating RNA recruitment into replication and the assembly of the viral
replicase complex (shown as a membrane-bound complex with multiple p33, p92
pol and additional host factors, HF, such as Hsp70 and Cdc34p).
Subsequently, eEF1A promotes minus-strand synthesis by facilitating initiation on the viral template RNA by the viral replicase.
doi:10.1371/journal.ppat.1001175.g005
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being made in this area due to the development of a new cell-free
assay based on yeast CFE [30,31]. The yeast CFE is capable of
assembling the tombusvirus replicase complex in vitro in 40–60 min
in the presence of recombinant p33/p92
pol and the viral
(+)repRNA [31], allowing for studies on direct roles of various
factors. We find that inhibition of eEF1A activity by either DB or
GM also inhibited the assembly of the tombusviral replicase
complex based on time-course experiments (Fig. 4B) as well as a
direct replicase assembly assay (Fig. 4C). On the contrary, the
replicase activity was not inhibited by these compounds after the
assembly took place (Fig. 4B–C). It is possible that after the
formation of the eEF1A-RdRp-repRNA complex DB or GM are
not effective in inhibiting the stimulatory effect of eEF1A on the
RNA synthesis by the viral RdRp. Additional in vitro experiments
with purified tombusvirus replicase preparations confirmed the
lack of inhibition of RNA synthesis by DB or GM (Fig. S4A) on
pre-assembled virus replicases.
The inhibition of the tombusvirus replicase complex by DB or
GM might come from the ability of these compounds to inhibit the
template RNA recruitment step (Fig. 4F). If the recruitment of the
viral (+)RNA is inhibited, then the assembly of the viral replicase
cannot take place in yeast or in vitro [21,22,31]. A target for GM and
DB could be the inhibition of binding between eEF1A and the viral
(+)RNA (Fig. 4D, E). Since the actual steps during the replicase
assembly process are not yet known, it is possible that eEF1A might
play additional roles in the assembly of the viral replicase complex.
The presented data are also in agreement with the function of
eEF1A as a chaperone of the viral RdRp. Binding between the
eEF1A and RdRp might alter the structure of the RdRp that
favors de novo initiation for RNA synthesis. Indeed, the chaperone
activity of eEF1A and its bacterial homolog EF-Tu has been
shown before [66,67]. Moreover, the EF-Tu-EF-Ts complex is
thought to function in the Qbeta replicase complex as a chaperone
for maintaining the active conformation of the RdRp protein [68].
Overall, the current work demonstrates two major functions for
eEF1A in TBSV replication (Fig. 5): (i) stimulation of the assembly
of the viral replicase complex, likely by facilitating the recruitment
of the viral RNA template into the replicase; and (ii) enhancement
of the minus-strand synthesis by promoting the initiation step.
These roles for eEF1A are separate from its canonical role in host
and viral protein translation.
Materials and Methods
Yeast strains and expression plasmids
Saccharomyces cerevisiae strain BY4741 (MATa his3D1 leu2D0
met15D0 ura3D0) was obtained from Open Biosystems (Huntsville,
AL, USA). Plasmid-borne TEF1/2 TKY strains (MATa ura3-52
leu2-3, 112 trp1-D1 lys2-20 met2-1 his4-713 tef1::LEU2 tef2D pTEF2
URA3) were published before [69,70,71,72]. The plasmid
pESCHIS4-ADH-His33/CUP1-DI-72 expressing Cucumber necrosis
virus (CNV) p33 and the TBSV replicon RNA, called DI-72, was
describedearlier[25].The LYS2-basedplasmid pRS317-Tet-His92,
expressing CNV p92 under the control of Tetracycline-regulatable
(Tet) promoter was constructed as follows: the Tet promoter
sequence was obtained from pCM189-His92/Tet [73] by digestion
with EcoRI and BamHI, and CNV p92 coding sequences from
pGAD-His92 [7] digested with BamHI and PstI, followed by ligation
into pRS317 vector treated with EcoRI and PstI. To generate
mutations within TEF1 coding sequence by random mutagenesis,
we constructed the TRP1-based plasmid pRS314-pTEF1-TEF1,
which expressedTEF1underthecontrolofitsnative promoter. The
TEF1 promoter sequence, the TEF1 coding region and the Cyc1
terminator sequences were amplified by PCR with the following
primer pairs, #2764 (CCGCGAGCTCATAGCTTCAAAAT-
GTTTCTAC)/#2765 (CCGCGGATCCGTAATTAAAACT-
TAGATTAGATTGC), #2768 (CCGCGGATCCAAAATGGG-
TAAAGAGAAGTCTC)/#1877 (CCGCCTCGAGTTATTTC-
TTAGCAGCCTTTTGAGCAGC), and #2769 CCGCCTCG-
AGGAGGGCCGCATCATGTAA/#2770 (CCGCGGTACCA-
GCTTGCAAATTAAAGCCTTC), respectively. This was fol-
lowed by cloning the PCR products into pRS314 digested with
SacI and KpnI.
Random mutagenesis of TEF1
The mutagenic PCR conditions were as follows: 50 mM KCl,
10 mM Tris (pH 8.3 at 25uC), 7 mM MgCl2,0 . 3m MM n C l 2,1m M
dCTP and dTTP each, 0.2 mM dGTP and dATP each, 0.2 mMo f
each primer, 20 pM of template DNA and 10 units of Taq polymerase
in a 10 ml reaction volume in 10 aliquots. The PCR was performed for
30 cycles at 94uCf o r1m i n ,5 0 uCf o r1m i n ,a n d7 2 uC for 1 min in a
conventional thermal cycler. Three overlapping ,300–500 bp N-,
central- and C-terminal segments of the TEF1 gene were ampli-
fied separately by PCR using primer pairs: #2767 (GTT-
TCAGTTTCATTTTTCTTGTTC)/#2788 (GAGTCCATCT-
TGTTGACAG), #2787 (CATCAAGAACATGATTACTGGT-
AC)/#2790 (GACGTTACCTCTTCTGATTTC) and #2789
(CGGTGTCATCAAGCCAGGT/#2771, (TTCGGTTAGAGC-
GGATGTGG), respectively.
Yeast transformation, plasmid shuffling and replication
screening of mutant yeast strains
Yeast strain TKY102 was co-transformed with constructs
pESCHIS4-ADH-His33/CUP1-DI-72 and pRS317-Tet-His92
to induce TBSV repRNA replication according to standard
Lithium acetate-PEG protocol [74]. The transformed yeast
cultures were grown in a Synthetic Complete (SC) media with
2% glucose lacking leucine, histidine, lysine and uracil (SC-
ULHK
2) by shaking at 29uC overnight. To completely suppress
TBSV replication before induction, 1 mg/ml Doxycycline was
added to the media to inhibit the expression of p92. The plasmid
pool carrying the randomly mutated TEF1 gene was introduced
into the yeast cells already transformed with the two virus
expression plasmids by in vivo gap repair mechanism via
homologous recombination (Fig. S1A) [75]. Briefly, pRS314-
pTEF1-TEF1 was digested with enzymes to truncate the TEF1
coding sequence, and then the digested plasmid was recovered.
The gapped plasmid (5–10 mg) was transformed together with
overlapping PCR (20 mg) products carrying the TEF1 mutations
created by random mutagenic PCR (see above). The transformed
yeast cells were selected on SC media lacking uracil, tryptophan,
leucine, histidine and lysine. The colonies were further streaked
onto SC media plate lacking tryptophan, leucine, histidine and
lysine (SC-TLHK
2) with 0.1% (w/v final) 5-Fluoroorotic Acid (5-
FOA) media to select against the URA3-based wild-type TEF1
plasmid (Fig. S1A). This selection was repeated once and the loss
of URA3 plasmid was confirmed by the inability of the yeast strains
to grow on uracil-minus media. The yeast cells carrying the
randomly mutated TEF1 were grown at 29uC for 24 h in SC-
TLHK
2 media with 50 mM CuSO4 to induce virus replication.
Total RNA extraction from yeast cells and Northern blotting and
Western blotting were done as previously described [7,25].
Replication assay using the whole cell extract
Whole cell yeast extract capable of supporting TBSV replication
in vitro was prepared as described [31]. The in vitro TBSV
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2 ml of whole cell extract, 0.5 mg DI-72 (+)repRNA transcript,
400 ng purified MBP-p33, 100 ng purified MBP-p92
pol (both
recombinant proteins were purified from E. coli), 30 mM HEPES-
KOH, pH 7.4, 150 mM potassium acetate, 5 mM magnesium
acetate, 0.13 M sorbitol, 0.4 ml actinomycin D (5 mg/ml), 2 mlo f
150 mM creatine phosphate, 0.2 ml of 10 mg/ml creatine kinase,
0.2 ml of RNase inhibitor, 0.2 ml of 1 M dithiothreitol (DTT), 2 ml
of 10 mM ATP, CTP, and GTP and 0.25 mM UTP and 0.1 mlo f
[
32P]UTP [31]. The reaction mixture was incubated at 25uC for
3 h. The reaction was terminated by adding 100 ml stop buffer (1%
sodium dodecyl sulfate [SDS] and 0.05 M EDTA, pH 8.0),
followed by phenol-chloroform extraction, isopropanol-ammonium
acetate precipitation, and a washing step with 70% ethanol as
described [52]. The newly synthesized
32P-labeled RNA products
were separated by electrophoresis in a 5% polyacrylamide gel
(PAGE) containing 0.56Tris-borate-EDTA (TBE) buffer with 8 M
urea. To detect the double-stranded RNA (dsRNA) in the cell-free
replication assay, the
32P-labeled RNA samples were divided into
two aliquotes: one half was loaded onto the gel without heat
treatment in the presence of 25% formamide, while the other half
was heat denatured at 85uC for 5 min in the presence of 50%
formamide [31]. S1 nuclease digestion to remove single-stranded
32P-labeled RNA was performed at 37uC for 30 min in a buffer
containing 5 mM sodium acetate (pH 4.5 at 25uC), 0.28 M NaCl,
4.5mM ZnSO4 and 40 U S1 nuclease (Boehringer).
Fractionation of the whole cell extract was done according to
[52]. The total extract was centrifuged at 21,0006 ga t4 uC for
10 min to separate the ‘‘soluble’’ (supernatant) and ‘‘membrane’’
(pellet) fraction. The pellet was re-suspended and washed with
buffer A (30 mM HEPES-KOH pH 7.4, 150 mM potassium
acetate, and 5 mM magnesium acetate) followed by centrifugation
at 21,0006ga t4 uC for 10 min and re-suspension of the pellet in
buffer A. In vitro TBSV replication in the fractions was performed
as described [31].
Protein purification from E. coli and yeast
Expression and purification of the recombinant TBSV p33 and
p92 and TCV p88C replication proteins from E. coli were carried
out as described earlier with modifications [54]. Briefly, the
expression plasmids were transformed separately into E. coli strain
BL21 Rosetta (DE3). Protein expression was induced using
isopropyl b-D-thiogalactopyranoside (IPTG) for 8 h at 16uC, then
the cells were collected by centrifugation (5,000 rpm for 5 min).
The recombinant TCV p88C protein was purified on an amylose
resin column (NEB), as described [54]. The cells were suspended
and sonicated in MBP column buffer containing 20 mM Tris-Cl
pH 8.0, 150 mM NaCl, 1 mM EDTA, 10 mM b-mercaptoethanol
and 1 mM phenylmethylsulfonyl fluoride (PMSF). The sonicated
extract was then centrifuged at 27,000 g for 10 min, followed by
incubation with amylose resin (NEB) for 1 h at 4uC. After washing
the resin 3 times with the column buffer and once with a low salt
column buffer (25 mM NaCl), the proteins were eluted with a low
salt column buffer containing 0.18% (V/W) maltose and 6% (V/V)
glycerol and stored at 280uC. MBP-p33 and MBP-p92
pol were
purified as above, except 30 mM HEPES-KOH pH 7.4 was used
instead of20 mMTris-Cl pH 8.0.eEF1Awas purified from yeastas
described [76] and stored in aliquots at the vapor temperature of
liquidnitrogen.Proteinfractions used forthereplication assayswere
95% pure, as determined by SDS-PAGE.
Replicase purification from yeast and in vitro RdRp assay
Yeast strains (WT, C42, C53, C62) were transformed
with plasmids pESCHIS4-ADH-HF33/CUP1-DI-72 expressing
6XHis- and Flag-tagged CNV p33 and the TBSV DI-72 repRNA,
and pRS317-Tet-His92, expressing CNV p92 under the control of
Tet promoter [25]. Co-purification was done according to a
previously described procedure with the following modification
[25]. Briefly, 200 mg of yeast cells were resuspended and
homogenized in TG buffer [50 mM Tris–HCl [pH 7.5], 10%
glycerol, 15 mM MgCl2, 10 mM KCl, 0.5 M NaCl, 0.1%
Nonidet P-40 (NP-40), and 1% [V/V] yeast protease inhibitor
cocktail (Ypic)] by glass beads using FastPrep Homogenizer (MP
Biomedicals). The yeast cell lysate was cleared by centrifugation at
5006g for 5 min at 4uC to remove unbroken cells and debris. The
membrane fraction containing the viral replicase complex was
collected by centrifugation at 21,0006 g for 15 min at 4uC and
then solubilized in 1 ml TG buffer with a buffer containing 1%
NP-40, 5% SB3–10 [caprylyl sulfobetaine] (Sigma), 1% [V/V]
Ypic via gentle rotation for 1 h min at 4uC. The solubilized
membrane fraction was centrifuged at 21,0006 g for 15 min at
4uC and the supernatant was incubated with 20 ml anti-FLAG
M2-agarose affinity resin (Sigma) pre-equilibrated with 0.7 ml TG
buffer. After 2 h of gentle rotation at 4uC, we washed the resin 5
times with TG buffer containing 1% NP-40, the resin-bound
replicase complex was eluted in 100 ml elution buffer [50 mM
Tris–HCl [pH 7.5], 10% glycerol, 15 mM MgCl2, 10 mM KCl,
0.05 M NaCl, 0.5% Nonidet P-40 (NP-40), 1% Ypic and
0.15 mg/ml Flag peptide (sigma)]. In vitro RdRp activity assay
was performed by using DI-72 RI(2) RNA template transcribed in
vitro by T7 transcription [25].
Gel mobility shift assay (EMSA) and co-purification of
eEF1A-repRNA
EMSA was performed in a 10 ml-reaction containing 20 mM
HEPES [pH 7.6], 50 mM KCl, 2 mM MgCl2, 1 mM DTT,
0.1 mM EDTA, 10% [vol/vol] glycerol, 10 U of RNase inhibitor,
10 nM
32P-labeled DI-72 (+) RNA probe and 0.5 mg purified
eEF1A protein [76]. Reactions were incubated at room temper-
ature for 20 min and then resolved by 4% nondenaturing
polyacrylamide gel as described previously [25].
For in vitro eEF1A-repRNA co-purification, DI-72(+) repRNA
was biotin-labeled in standard T7 transcription reaction in the
presence of 20 mM Biotin-16-UTP (Roche). After the T7
transcription, the unincorporated biotin-UTP was removed on a
Bio-Rad mini gel filtration column. The biotinylated RNA was
immobilized on a column containing Streptavidin MagneSphere
Paramagnetic Particles (SA-PMPs). Briefly, a 30-ml suspension of
SA-PMPs (Promega) was washed three times with 1 ml of water
and re-suspended in 16 Phosphate Buffered Saline (PBS).
Biotinylated DI-72(+) RNA (5 mg) was then added to the
suspension of SA-PMPs, followed by 30 min incubation at 4uC
with gentle rotation. The SA-PMPs were collected on the side of
the tube in a magnetic stand and washed 3 times with 16 PBS
buffer. eEF1A was translated in vitro and labeled with
35S
methionine using Rabbit Reticulocyte Lysate (Promega) according
to manufacturer’s manual. The in vitro eEF1A translation product
(10 ml) was pre-incubated in a 200 ml binding buffer (20 mM
HEPES [pH 7.6], 50 mM KCl, 2 mM MgCl2, 1 mM DTT,
1 mM GTP, 0.1 mM EDTA, 10% [V/V] glycerol, 1% BSA,
10 U of RNase inhibitor and 0.2% NP-40) with 150 mM
Didemnin B (final concentration) or DMSO for 30 min at 30uC
and then incubated with biotinylated DI-72(+) RNA-bound SA-
PMPs for 1 h at 4uC. The SA-PMPs were collected in a magnetic
stand and washed 5 times with the binding buffer, followed by
elution with 30 ml SDS-PAGE sample buffer. The eluted protein
samples were resolved by SDS-PAGE and then exposed to
phosphorimager.
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The TCV RdRp reactions were carried out as previously
described for 2 h at 25uC [54]. Briefly, the RdRp reactions were
performed in a 20 ml reaction containing 50 mM Tris-HCl
(pH 8.2), 10 mM MgCl2, 10 mM DTT, 1.0 mM each ATP,
CTP, and GTP, 0.01 mM UTP plus 0.1 mlo f[
32P]UTP, 7 pmol
template RNA, 2 pmol affinity-purified MBP-p88C. 20 pmol
eEF1A was added to the reaction at the beginning or as indicated
in the text and Fig. 3 legend. The
32P-labeled RNA products were
analyzed by electrophoresis in a 5% or 15% PAGE/8 M urea gel
[57]. The 86-nt 39 noncoding region of TBSV genomic RNA was
used as the template in the RdRp assay [25,54].
The use of eEF1A inhibitors in the in vitro replicase
assembly assay
Purified Didemnin B (NSC 325319) was kindly provided by the
Natural Products Branch, NCI (Bethesda, MD, USA), while
Gamendazole was a generous gift from Dr. Tash (University of
Kansas Medical Center). Both chemicals were dissolved in DMSO
(the final concentration was 20 mM). The concentrations of
chemical and time point of the addition of the chemicals to the in
vitro reaction are indicated in the text. The cell-free TBSV
replicase assay and the in vitro TBSV replicase assembly assay were
performed according to [31]. Briefly, the purified recombinant
TBSV p33, p92
pol and (+) repRNA were added to the cell-free
reaction in the presence of 1.0 mM ATP and GTP in step 1. After
incubation at 25uC for 1 h, the in vitro reactions were centrifuged
21,0006 ga t4 uC for 10 min. The supernatant containing extra
p33, p92
pol and repRNA, which were not bound to the
membranes in the cell-free extract, was discarded, while the
membrane pellet was re-suspended in a standard in vitro replicase
assay buffer containing [
32P]-UTP and ATP, CTP, and GTP, and
incubated at 25uC for 3 h [31].
In vitro viral RNA recruitment assay
The TBSV viral RNA gets recruited to the membrane from the
soluble fraction with the help of TBSV replication proteins and host
factors present in the yeast CFE. The in vitro RNA recruitment
reaction was performed according to [31], except that
32P-labeled
DI-72 (+)repRNA were used and rCTP, rUTP,
32P-labeled UTP,
and Actinomycin D were omitted from the reaction. As a negative
control, a recruitment-deficient repRNA, termed C99-G mutant,
was used (Fig. 4F, lane 2) [23]. This mutant RNA is not recognized
by p33/p92 replication proteins and it does not replicate in plants,
in yeast or in the CFE in vitro [23,31,52,77]. The RNA recruitment
assay results in the assembly of the functional viral replicase, when
wt repRNA is used, and nonfunctional replicase when the C99-G
mutant is used in the assay (J. Pogany and P.D. Nagy, not shown)
[31]. Inhibitors DB and GM were added at final concentration of
150 and 100 mM, respectively. After two hours of incubation at
room temperature, 1 ml of reaction buffer was added to the in vitro
assay, followed by incubation on ice for 10 min. Samples were
centrifuged at 35,0006 g for 1h, and the pellet was washed with
1 ml reaction buffer, followed by centrifugation at 35,0006g for
10 min. The membrane-bound repRNA was extracted from the
pellet by adding 0.1 ml stop buffer and 0.1 ml phenol/chloroform
and vortexing, followed by isopropanol/ammonium acetate
precipitation [52]. The RNA samples were analyzed by denaturing
PAGE and phophoimaging as described [52].
Supporting Information
Figure S1 Schematic presentation of the random mutagenesis
strategy used to obtain 6,000 eEF1A mutants. (A) The yeast strain
(tef1Dtef2D carried a plasmid that expressed one of the random
eEF1A (TEF1) mutants from the native promoter. Each yeast
strain also carried pESCHIS4-ADH-His33/CUP1-DI-72 and
pRS317-Tet-His92 to induce TBSV repRNA replication as
described in the M&M section. (B) Additional experiments on
the effect of eEF1A mutations on TBSV repRNA accumulation in
yeast. The yeast strain expressed only one form of eEF1A, as
indicated. Top panel: Replication of the TBSV repRNA was
measured by Northern blotting 24 h after initiation of TBSV
replication. (C) The accumulation level of repRNA was normal-
ized based on the rRNA (the 18S ribosomal RNA levels were
estimated by Northern blotting). Panels (D), (E) and (F) show the
accumulation of p92
pol, p33 and eEF1A, respectively, estimated by
Western blotting using anti-His and anti-eEF1A antibody. (G)
SDS-PAGE analysis of total protein extract from the above yeast
strains, after Coomassie blue-staining.
Found at: doi:10.1371/journal.ppat.1001175.s001 (0.15 MB PDF)
Figure S2 Binding of eEF1A to TBSV and TCV replication
proteins in vitro. (A) MBP-tagged TCV p88C (lacking the p28-
overlapping domain from the N-terminus), MBP-TBSV p92,
MBP-TBSV p92C (lacking the p33-overlapping domain from the
N-terminus) and MBP-TBSV p33 or MBP (1 mg each) were
separately immobilized on amylose beads, followed by incubation
with a cytosolic extract prepared from yeast. The bound host
proteins were eluted from the beads and were analyzed by 10%
SDS-PAGE and detected via Western blotting using anti-eEF1A
antibody (Top panel). The affinity-purified recombinant MBP-
TCV p88C, MBP-TBSV p92, MBP-TBSV p92C, MBP-TBSV
p33 and MBP were analyzed by 10% SDS-PAGE and Coomassie
blue-staining (Bottom panel). (B) The effect of eEF1A mutations on
binding to the viral p33 and p92 proteins in vitro. MBP-tagged p92,
p33 or MBP were separately immobilized on amylose beads,
followed by incubation with a cytosolic extract prepared from
yeast expressing wt or mutated eEF1A. The bound eEF1A was
eluted from the beads and were analyzed by 10% SDS-PAGE and
detected via Western blotting using anti-eEF1A antibody (Top
panel). The affinity-purified recombinant MBP-TBSV p92, MBP-
TBSV p33 and MBP were analyzed by 10% SDS-PAGE and
Coomassie blue-staining (Bottom panel). (C) The effect of eEF1A
mutations on binding to the viral repRNA. CFE containing WT or
mutated eEF1A was incubated with biotin-labeled DI-72(+)
repRNA. Then the repRNA was captured with streptavidin-
coated magnetic beads, followed by elution of the co-purified
proteins from the beads. Western blot analysis shows the amount
of co-purified eEF1A using anti-eEF1A antibody.
Found at: doi:10.1371/journal.ppat.1001175.s002 (0.12 MB PDF)
Figure S3 Lack of inhibition of TBSV repRNA replication by
Cyclohexamide in a cell-free TBSV replicase assay. The cell-free
TBSV replicase assay was performed as described in Fig. 4.
Cyclohexamide was added in the following amounts: 0, 2, 10, 50,
100 mg/ml.
Found at: doi:10.1371/journal.ppat.1001175.s003 (0.05 MB PDF)
Figure S4 Lack of inhibition of the in vitro activity of the purified
tombusvirus replicase by Didemnin B and Gamendazole. (A) The
membrane-bound tombusvirus replicase in a yeast lysate was
solubilized with Triton X-100/SB3-10 detergent, followed by
purification on a FLAG-affinity column as described. The activity
of the affinity-purified TBSV replicase was tested on the same
amount of DI-72(2) RNA added to each sample. DB (panel on the
left) and GM (panel on the right) were added in the following
amounts: 0, 100, 150, 200, 250 mM for DB and 0, 25, 50, 100,
200 mM for GM. Denaturing PAGE analysis of the
32P-labeled
RNA products obtained with the purified tombusvirus replicase is
eEF1A Role in the Assembly of Virus Replicase
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complementary RNA synthesis on the added template RNA, but
incapable of supporting a full cycle of replication. (B) The effect of
GM and DB on binding to the viral p33 and p92 proteins in vitro.
MBP-tagged p92 and p33 were separately immobilized on
amylose beads, followed by incubation in the presence of 0 or
100 mM GM or 150 mM DB with a cytosolic extract prepared
from yeast expressing wt eEF1A. The bound eEF1A was eluted
from the beads and were analyzed by 10% SDS-PAGE and
detected via Western blotting using anti-eEF1A antibody (Top
panel). The affinity-purified recombinant MBP-TBSV p92, MBP-
TBSV p33 and MBP were analyzed by 10% SDS-PAGE and
Coomassie blue-staining (Bottom panel).
Found at: doi:10.1371/journal.ppat.1001175.s004 (0.09 MB PDF)
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